First Antimicrobial Resistance Benchmark – how will it work?
To understand better how our forthcoming Antimicrobial Resistance Benchmark was developed and how this tool will be used to track pharmaceutical company action to tackle AMR, Carola Timmel interviews our Executive Director, Jayasree K. Iyer.
Date
28 September 2017